{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-000253","form_type":"8-K","ticker":"BVS","cik":"0001665988","company_name":"Bioventus Inc.","filed_at":"2025-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.368567+00:00","generated_at":"2026-05-28T14:37:37.445971+00:00","sec_items":["2.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bioventus completes divestiture of Advanced Rehab business to Accelmed for $25M cash plus $20M earn-out","bullets":["Closed sale of Advanced Rehabilitation business to Accelmed Partners on Dec 31, 2024.","Received $25M cash at closing, subject to working capital adjustments.","Up to $20M in earn-out payments based on 2025-2026 revenue and EBITDA thresholds.","Net closing proceeds of approx $20M to enhance liquidity; company to focus on core businesses.","Accelmed is a private equity firm focused on commercial-stage HealthTech companies."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-000253","json":"https://secwatch.observer/filing/0001628280-25-000253.json","markdown":"https://secwatch.observer/filing/0001628280-25-000253.md","text":"https://secwatch.observer/filing/0001628280-25-000253.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1665988/000162828025000253/0001628280-25-000253-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1665988/000162828025000253/bvs-20241231.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T14:37:37.445971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}